An Integrated Development and Manufacturing Organization (IDMO) specializing in cell therapies.
Healthcare📍 South San Francisco, CA
Current Valuation
Private
PRIVATE
An Integrated Development and Manufacturing Organization (IDMO) specializing in cell therapies. Headquartered in South San Francisco, CA. Raised $50M in Series D funding in June 2026 led by Prime Radiant Partners.
Company Profile
CEO
Fabian Gerlinghaus
HQ
South San Francisco, CA
Total Raised
$327M
Last Round
Series D — $50M (Jun 2026) · Lead: Prime Radiant Partners
IPO Status
private
Fundraising Status
Series D · $50M · 2 mo ago
privateTotal raised $327M1 disclosed rounds
Secondary Market
Implied price / share
$7.57
Last round price / share
$8.51
vs last round
-11.0%
Open interest
2
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Funding History
Round
Amount
Date
Lead Investor
Post-Money
Series D
$50M
Jun 2026
Prime Radiant Partners
—
Investors
Prime Radiant Partners
HealthcareBiotechnologyRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.